Cerebral amyloid angiopathy impact on endothelium


Autoria(s): Grinberg, Lea Tenenholz; Korczyn, Amos D.; Heinsen, Helmut
Contribuinte(s)

UNIVERSIDADE DE SÃO PAULO

Data(s)

29/10/2013

29/10/2013

2012

Resumo

Cerebral amyloid angiopathy (CAA) is an age-associated disease characterized by amyloid deposition in cerebral and meningeal vessel walls. CAA is detected in the majority of the individuals with dementia and also in a large number of non-demented elderly individuals. In addition, CAA is strongly associated with Alzheimer's disease (AD) pathology. Mechanical consequences including intra-cerebral or subarachnoid hemorrhage remains CAA most feared complication, but only a small fraction of CAA results in severe bleeding. On the hand the non-mechanical consequences in cerebrovascular regulation are prevalent and may be even more deleterious. Studies of animal models have provided strong evidence linking the vasoactive A beta 1-40, the main species found in CAA, to disturbances in endothelial-dependent factors, disrupting cerebrovascular regulation Here, we aimed to review experimental findings regarding the non-mechanical consequences of CAA for cerebrovascular regulation and discuss the implications of these results to clinical practice. (C) 2012 Elsevier Inc. All rights reserved.

National Institute of Health [R01AG040311-01A1, P50 AG023501-06]

National Institute of Health

John Douglas French Alzheimer Foundation

John Douglas French Alzheimer Foundation

Albert Einstein Research Institute - Sao Paulo

Albert Einstein Research Institute Sao Paulo

Identificador

EXPERIMENTAL GERONTOLOGY, OXFORD, v. 47, n. 11, supl. 1, Part 3, pp. 838-842, NOV, 2012

0531-5565

http://www.producao.usp.br/handle/BDPI/36298

10.1016/j.exger.2012.08.005

http://dx.doi.org/10.1016/j.exger.2012.08.005

Idioma(s)

eng

Publicador

PERGAMON-ELSEVIER SCIENCE LTD

OXFORD

Relação

EXPERIMENTAL GERONTOLOGY

Direitos

closedAccess

Copyright PERGAMON-ELSEVIER SCIENCE LTD

Palavras-Chave #AMYLOID #ANGIOPATHY #DEMENTIA #ALZHEIMER'S DISEASE #ANIMAL MODELS #ENDOTHELIUM #CEREBROVASCULAR DYSFUNCTION #BLOOD BRAIN BARRIER #TRANSGENIC MOUSE MODEL #SMOOTH-MUSCLE CELLS #BLOOD-BRAIN-BARRIER #ALZHEIMERS-DISEASE BRAINS #NADPH OXIDASE #A-BETA #SCAVENGER RECEPTOR #PRECURSOR PROTEIN #CEREBROVASCULAR LESIONS #VASCULAR DEMENTIA #GERIATRICS & GERONTOLOGY
Tipo

article

original article

publishedVersion